Omeros News and Activities

Presence

Omeros develops and commercializes medicines for immune, inflammatory, and neurological disorders. Its services include drug discovery, clinical development, and specialty pharmaceuticals for hospitals, physicians, and patients.

Omeros products and services overview:

  • Drug discovery
  • Clinical development
  • Immunology therapies
  • Neurology therapies
  • Hospital pharmaceuticals

Revenue: ~$2 million

Employees: 90

Headquarters: Seattle, United States (USA)


Omeros is one of the...

Omeros is a company listed under the stock ticker OMER (US).

Executives

View the org chart displaying its 26 main executives

Most searched biographies at Omeros
Popular executive movements at Omeros
  • Nadia Dac, Chief Commercial Officer, has left the company  (posted on May 5 2026).

Create your alert
to follow the executive moves at Omeros.

Pharmaceuticals

Omeros has 1,913 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals
Popular contacts in Pharmaceuticals

Learn more about the Pharmaceuticals industry

News

Press releases by Omeros
Social media about Omeros

Get in Touch

Call Omeros at +1 206...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board